Cogent Biosciences COGT
NASDAQ COGT
$31.59 -0.43 (-1.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)

Updated

Cogent Biosciences (COGT) reported Change in Receivables of -$2 million for FY2020, compared with $332,000 in FY2019.

Analysis

Cogent Biosciences (COGT) Change in Receivables (2017 - 2020) Analysis & Trends

Dating back to FY2017, Cogent Biosciences' Change in Receivables record includes 4 years.

  • According to Business Quant data, Change in Receivables came in at $332,000 in FY2019 (-60.4%), $838,000 in FY2018 and -$98,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Cogent Biosciences 5.49 Bn 5.49 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -2.00 Mn
Dec 31, 2019 1.12 Mn
Sep 30, 2019 -612,000.00
Jun 30, 2019 -548,000.00
Mar 31, 2019 372,000.00
Dec 31, 2018 249,000.00
Sep 30, 2018 217,000.00
Jun 30, 2018 -399,000.00
Mar 31, 2018 771,000.00
Dec 31, 2017 -681,000.00
Sep 30, 2017 253,000.00
Jun 30, 2017 371,000.00
Mar 31, 2017 -41,000.00
API Access

Cogent Biosciences Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=COGT&period=max&api_key=YOUR_API_KEY